Happy to announce our next event in which experts in the field of ATMPs will discuss their work over the past year to utilise their knowledge of #advancedtherapies to combat COVID-19. Register now: restore-horizon.eu/covid-19-and-a… Charité - Universitätsmedizin Berlin @antonio81460709 @berlinnovation

Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective pubmed.ncbi.nlm.nih.gov/35186986/ Leila Amini @BIHregeneration

A team at Charité - Universitätsmedizin Berlin including Dr. Leila Amini propose adoptive transfer of SARS-CoV-2-specific T cells made resistant to a common immunosuppressant, Tacrolimus, to prevent and treat severe COVID-19 in #immunosuppressed patients. bit.ly/3KsGDuj

Tacrolimus-resistant SARS-CoV-2-specific T-cell products to prevent and treat severe COVID-19 in immunosuppressed patients: Molecular Therapy - Methods & Clinical Development cell.com/molecular-ther…

New Research: Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective: Rejection of solid organ transplant and graft versus host disease (GvHD) continue to be challenging in post transplantation management.… frontiersin.org/articles/10.33… #celldevbio

Check out our Review article about adoptive regulatory T cell therapy: frontiersin.org/articles/10.33…

check out our TReAT project website: treat-project.com

Ending the year with a great TReAT meeting with many of our collaboration partners. Discussing achieved goals and next steps for 2024 🥳 Thank you all for your great efforts! @LabMsh Oliver Klein Leila Amini

Our phd student Claudia won the 3rd poster price at the BSRT Symposium @BIHregeneration 🥳🥳🥳

#LiverTransplant is a game changer, but organ rejection remains a challenge, especially in kids. Excited about funding from Charité BIH Innovation @BIHregeneration for our project w Leila Amini, Oliver Klein, Frank Tacke🙏New human rejection models for T-cell therapy! #livertwitter

We are proud to present our new advanced course on ATMPs: eithealth.eu/programmes/pro…

Exciting PhD Opportunity in Liver Transplantation! We offer a new PhD student an excellent candidate who is focused on pioneering research in Regulatory T Cell Therapy for transplant rejection using organoids! Send motivation letter and CV. Charité BIH Innovation @BIHregeneration

bioRxiv Clinical development of gene edited tacrolimus-resistant Treg (FKBP12KO-Treg) to enable simultaneous immunosuppression and support of immune regulation Leila Amini biorxiv.org/content/10.648…